| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.029 | 0.6 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |